Immunoregulation of Bone Remodelling

Overview

Journal Int J Crit Illn Inj Sci

Specialty Critical Care

Date 2012 Jul 28

PMID 22837895

Citations 16

Authors

Ajai Singh

Abbass A Mehdi

Rajeshwer N Srivastava

Nar Singh Verma

Affiliations

Soon will be listed here.

Abstract

Remodeling, a continuous physiological process maintains the strength of the bones, which maintains a delicate balance between bone formation and resorption process. This review gives an insight to the complex interaction and correlation between the bone remodeling and the corresponding changes in host immunological environment and also summarises the most recent developments occuring in the understanding of this complex field. T cells, both directly and indirectly increase the expression of receptor activator of nuclear factor kB ligand (RANKL); a vital step in the activation of osteoclasts, thus positively regulates the osteoclastogenesis. Though various cytokines, chemikines, transcription factors and co-stimulatory molecules are shared by both skeletal and immune systems, but researches are being conducted to establish and analyse their role and / or control on this complex but vital process. The understanding of this part of research may open new horizons in the management of inflammatory and autoimmune diseases, resulting into bone loss and that of osteoporosis also.

Citing Articles

From gut to bone: deciphering the impact of gut microbiota on osteoporosis pathogenesis and management.

Hao L, Yan Y, Huang G, Li H Front Cell Infect Microbiol. 2024; 14:1416739.

PMID: 39386168 PMC: 11461468. DOI: 10.3389/fcimb.2024.1416739.

Bridging the Gap in Understanding Bone Metastasis: A Multifaceted Perspective.

Elaasser B, Arakil N, Mohammad K Int J Mol Sci. 2024; 25(5).

PMID: 38474093 PMC: 10932255. DOI: 10.3390/ijms25052846.

Protective effects of curcumin against osteoporosis and its molecular mechanisms: a recent review in preclinical trials.

Yang S, Sun Y, Kapilevich L, Zhang X, Huang Y Front Pharmacol. 2023; 14:1249418.

PMID: 37790808 PMC: 10544586. DOI: 10.3389/fphar.2023.1249418.

Macrophages-bone marrow mesenchymal stem cells crosstalk in bone healing.

Fan S, Sun X, Su C, Xue Y, Song X, Deng R Front Cell Dev Biol. 2023; 11:1193765.

PMID: 37427382 PMC: 10327485. DOI: 10.3389/fcell.2023.1193765.

Unraveling the potential of 3D bioprinted immunomodulatory materials for regulating macrophage polarization: State-of-the-art in bone and associated tissue regeneration.

Dutta S, Ganguly K, Patil T, Randhawa A, Lim K Bioact Mater. 2023; 28:284-310.

PMID: 37303852 PMC: 10248805. DOI: 10.1016/j.bioactmat.2023.05.014.

References

Eghbali-Fatourechi G, Khosla S, Sanyal A, Boyle W, Lacey D, Riggs B . Role of RANK ligand in mediating increased bone resorption in early postmenopausal women. J Clin Invest. 2003; 111(8):1221-30. PMC: 152939. DOI: 10.1172/JCI17215. View

Tripmacher R, Gaber T, Dziurla R, Haupl T, Erekul K, Grutzkau A . Human CD4(+) T cells maintain specific functions even under conditions of extremely restricted ATP production. Eur J Immunol. 2008; 38(6):1631-42. DOI: 10.1002/eji.200738047. View

Palmqvist P, Persson E, Conaway H, Lerner U . IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-kappa B ligand, osteoprotegerin, and receptor activator of NF-kappa B in mouse calvariae. J Immunol. 2002; 169(6):3353-62. DOI: 10.4049/jimmunol.169.6.3353. View

Li J, Sarosi I, Yan X, Morony S, Capparelli C, Tan H . RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci U S A. 2000; 97(4):1566-71. PMC: 26475. DOI: 10.1073/pnas.97.4.1566. View

Huang W, OKeefe R, Schwarz E . Exposure to receptor-activator of NFkappaB ligand renders pre-osteoclasts resistant to IFN-gamma by inducing terminal differentiation. Arthritis Res Ther. 2003; 5(1):R49-59. PMC: 154432. DOI: 10.1186/ar612. View

Parfitt A . Osteonal and hemi-osteonal remodeling: the spatial and temporal framework for signal traffic in adult human bone. J Cell Biochem. 1994; 55(3):273-86. DOI: 10.1002/jcb.240550303. View

Huang Y, Harrison J, Lorenzo J, Kream B . Parathyroid hormone induces interleukin-6 heterogeneous nuclear and messenger RNA expression in murine calvarial organ cultures. Bone. 1998; 23(4):327-32. DOI: 10.1016/s8756-3282(98)00115-x. View

Shoji M, Tanabe N, Mitsui N, Tanaka H, Suzuki N, Takeichi O . Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts. Life Sci. 2005; 78(17):2012-8. DOI: 10.1016/j.lfs.2005.09.019. View

Noble B, Peet N, Stevens H, Brabbs A, Mosley J, Reilly G . Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol. 2002; 284(4):C934-43. DOI: 10.1152/ajpcell.00234.2002. View

10.

Kwon B, Wang S, Udagawa N, Haridas V, Lee Z, Kim K . TR1, a new member of the tumor necrosis factor receptor superfamily, induces fibroblast proliferation and inhibits osteoclastogenesis and bone resorption. FASEB J. 1998; 12(10):845-54. DOI: 10.1096/fasebj.12.10.845. View

11.

Kong Y, Yoshida H, Sarosi I, Tan H, Timms E, Capparelli C . OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature. 1999; 397(6717):315-23. DOI: 10.1038/16852. View

12.

Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H . Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell. 2002; 3(6):889-901. DOI: 10.1016/s1534-5807(02)00369-6. View

13.

Simonet W, Lacey D, Dunstan C, Kelley M, Chang M, Luthy R . Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell. 1997; 89(2):309-19. DOI: 10.1016/s0092-8674(00)80209-3. View

14.

Greenfield E, Horowitz M, Lavish S . Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. J Biol Chem. 1996; 271(18):10984-9. DOI: 10.1074/jbc.271.18.10984. View

15.

Liu D, Yao S, Wise G . Effect of interleukin-10 on gene expression of osteoclastogenic regulatory molecules in the rat dental follicle. Eur J Oral Sci. 2006; 114(1):42-9. DOI: 10.1111/j.1600-0722.2006.00283.x. View

16.

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

17.

Malyankar U, Scatena M, Suchland K, Yun T, Clark E, Giachelli C . Osteoprotegerin is an alpha vbeta 3-induced, NF-kappa B-dependent survival factor for endothelial cells. J Biol Chem. 2000; 275(28):20959-62. DOI: 10.1074/jbc.C000290200. View

18.

Oursler M, Cortese C, Keeting P, Anderson M, Bonde S, Riggs B . Modulation of transforming growth factor-beta production in normal human osteoblast-like cells by 17 beta-estradiol and parathyroid hormone. Endocrinology. 1991; 129(6):3313-20. DOI: 10.1210/endo-129-6-3313. View

19.

Dresner-Pollak R, Gelb N, Rachmilewitz D, Karmeli F, Weinreb M . Interleukin 10-deficient mice develop osteopenia, decreased bone formation, and mechanical fragility of long bones. Gastroenterology. 2004; 127(3):792-801. DOI: 10.1053/j.gastro.2004.06.013. View

20.

Lum L, Wong B, Josien R, Becherer J, Erdjument-Bromage H, Schlondorff J . Evidence for a role of a tumor necrosis factor-alpha (TNF-alpha)-converting enzyme-like protease in shedding of TRANCE, a TNF family member involved in osteoclastogenesis and dendritic cell survival. J Biol Chem. 1999; 274(19):13613-8. DOI: 10.1074/jbc.274.19.13613. View